Medical Professionals
Our flagship product, Vertica, represents groundbreaking advancement in the field of non-invasive, user-friendly home treatments for erectile dysfunction. Developed by experts in advanced technologies, Vertica embodies a clinically-oriented approach to medical device innovation.
We continue our commitment to medical excellence and maintain active partnerships with leading urologists to conduct ongoing clinical trials aimed at broadening Vertica's applications and enhancing its efficacy. The proven Vertica technology provides a platform for the development of treatment solutions for a growing range of urological indications such as Peyronie and post-radical prostatectomy,
Our dedication to innovation aligns closely with the stringent standards expected of medical devices.
Clinical Investigation
Prior to public release, our company conducted a pilot study to evaluate the feasibility, effectiveness, and safety profile of Vertica®. Led by Principal Investigator Prof. Ilan Gruenwald, this pilot clinical study took place at the Neuro-urology unit, Rambam Healthcare Campus, Israel.
Detailed findings of the study are accessible here.
Pilot Study Results
Twenty-eight men with a minimum six-month history of erectile dysfunction participated in the study, revealing that 85% experienced improved erectile function. A subsequent six-month follow-up study demonstrated the sustained efficacy of Vertica treatment.
Participants underwent a regimen of 12 treatments with the Vertica® device, comprising two treatments per week over four weeks (eight sessions in total), followed by one treatment per week for an additional four weeks (four sessions in total). Treatment administration was self-managed by participants according to provided instructions.
The study concluded with positive changes observed in both subjective and objective measures of erectile function, without any reported adverse events.
Continued Clinical Research
Ohh-Med is presently engaged in an IRB-approved randomized controlled trial (RCT) clinical study across several sites in the USA to assess the effectiveness of Vertica for the treatment of Erectile Dysfunction. The stringent protocol was designed together with the FDA to enable submission at the end of the study.
The site currently active is: UCI (University of California - Irvine), under the guidance of Dr. Faysal Yafi.
Additionally, we are collaborating with leading international urologists to expand our clinical research efforts, exploring further indications for Vertica treatment, including Peyronie’s disease, penile rehabilitation after radical prostatectomy, and beyond.
Clinical Information
Clinical Presentation at ISSM 2023
Prof. Yacov Reisman, MD, PhD, FECSM, ECPS presents the latest clinical data from the first pilot study. View it here.
Slides for Download
Download our clinical presentation to view the latest clinical data about Vertica. Feel free to download our slides and incorporate them in your own presentations.
CLINICAL
RESOURCES
ASK OUR EXPERT
Professor Ilan Gruenwald has been leading the Neurourology unit, Rambam Medical Center for over 10 years. He has been intimately involved in the development of Vertica and was the PI of the first pilot study.
Please feel free to contact Prof Gruenwald if you have clinical questions for your patients.
